Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19.
Diana Badenes BonetOswaldo Antonio Caguana VélezXavier Duran JordàMerce Comas SerranoMargarita Posso RiveraMireia AdmetllóAnna Herranz BlascoElisa Cuadrado GodiaEster MarcoGemma Martin EzquerraZenaida Pineiro AguinMaria Cinta Cumpli GargalloJose Gregorio Gonzalez GarciaEva Balcells VilarnauDiego A Rodríguez-ChiaradíaXavier CastellsJoaquim GeaJuan Pablo HorcajadaJudit Villar-Garcíanull nullPublished in: Journal of clinical medicine (2023)
Treatment with dexamethasone and/or remdesivir may be useful to reduce the impact of PASC secondary to SARS-CoV-2 infection. In addition, we identified female gender, obesity, asthma, and disease severity as risk factors for having PASC.